Trial intelligence / Profile preview

Remimazolam vs propofol with alfentanil for outpatient painless colonoscopy

ChiCTR2100053470Phase 4Recruiting

Sponsor
Weifang People's Hospital
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Intraoperative adverse events. Started Dec 2021; status: recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2100053470.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100053470.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call